Ambra Health is a technology company.
Ambra Health has raised $19.0M across 3 funding rounds.
Ambra Health has raised $19.0M in total across 3 funding rounds.
Ambra Health has raised $19.0M in total across 3 funding rounds.
Ambra Health's investors include Canaan Partners.
Ambra Health is a cloud-based SaaS company specializing in medical data and image management, offering solutions for enterprise image exchange, archiving, viewing, reporting, and de-identification for research.[1][2][5] It serves large hospital systems, radiology practices, cardiology groups, clinical research organizations, health information exchanges, and subspecialty practices like OB/GYN, enabling seamless DICOM and non-DICOM image sharing across providers, patients, and EHR systems to streamline workflows and improve patient care.[1][2][3] The platform solves critical challenges in medical imaging by providing scalable, interoperable tools like Vendor Neutral Archive (VNA), Picture Archiving and Communication System (PACS), and automated routing, reducing technical barriers, enhancing collaboration, and supporting remote access.[1][2][3] Growth momentum includes KLAS #1 rankings for medical image exchange for eight consecutive years through 2022, double-digit revenue growth post-2021 acquisition by Intelerad, and a 170% increase in global customer base, with trusted users like Stanford Children’s Health and Memorial Hermann.[1][6]
Founded in 2004 as DICOM Grid, Inc. in New York, NY, Ambra Health pioneered cloud-based digital medical imaging to enable storage, access, and sharing of diagnostic images and health data for providers and patients.[2] The company launched its DG Suite platform, which gained HIPAA approval and earned "best in KLAS" awards from 2014-2017, plus the 2016 SIIA CODiE award, building early traction with 750 healthcare providers by 2017.[2] In September 2016, it rebranded to Ambra Health (a DBA of DICOM Grid), expanding focus on intuitive, scalable image management.[2] Key leaders include CEO Morris Panner and CTO Geoff Crawshaw.[2] A pivotal moment came in October 2021 when Intelerad acquired Ambra Health, integrating it into a broader portfolio and fueling accelerated adoption amid rising demand for cloud imaging solutions post-pandemic.[6]
Ambra Health rides the shift to cloud-native healthcare IT, addressing fragmentation in medical imaging amid rising telemedicine, remote diagnostics, and data-driven research post-pandemic.[1][6] Timing aligns with healthcare's push for interoperability under regulations like HIPAA and growing EHR adoption, where legacy on-premises systems hinder efficiency—Ambra's agile deployment cuts costs and barriers.[1][3] Market forces like increasing imaging volumes, life sciences demand for anonymized datasets, and provider consolidation favor its scalable SaaS model, influencing the ecosystem by enabling collaborative networks (e.g., via RSNA Image Share) and setting standards for vendor-neutral solutions.[2][6] As part of Intelerad, it accelerates cloud migration for hospitals and practices, boosting clinical outcomes and business performance in a $10B+ imaging informatics market.[1][5]
Ambra Health's integration into Intelerad positions it for expanded global reach, with ongoing KLAS leadership signaling sustained demand for cloud imaging amid AI-enhanced diagnostics and value-based care trends.[6] Expect growth via deeper EHR integrations, AI-driven analytics, and research tools, as healthcare digitizes further—potentially capturing more subspecialty and international markets.[1][3] Its influence will evolve from workflow enabler to foundational platform for imaging innovation, delivering better care through technology at the heart of provider networks, as momentum builds on proven traction.[1][6]
Ambra Health has raised $19.0M across 3 funding rounds. Most recently, it raised $6.0M Venture Round in July 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2014 | $6.0M Venture Round | Canaan Partners | |
| May 1, 2012 | $5.0M Series B | Canaan Partners | |
| Nov 1, 2010 | $8.0M Series A | Canaan Partners |